E47-Nondamaging Retinal Laser for Mac Tel Type II- Dr. Daniel Lavinsky

Dr. Daniel Lavinsky describes the results of a small randomized controlled clinical trial investigating functional and anatomical outcomes of using nondamaging retinal laser for the treatment of macular telangiectasia type II. The discussed article: Lavinsky D, Silva MOD, Chaves AE, Schneider WFM, Lavinsky F, Palanker D. FUNCTIONAL AND STRUCTURAL EFFECTS OF NONDAMAGING RETINAL LASER THERAPY FOR MACULAR TELANGIECTASIA TYPE 2: A Randomized Sham-Controlled Clinical Trial. Retina. 2021 Mar 1;41(3):487-494. doi: 10.1097/IAE.0000000000002882. PMID: 33370517.

Episode metadata supplied by the publisher feed · Published Mar 13, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

E47-Nondamaging Retinal Laser for Mac Tel Type II- Dr. Daniel Lavinsky

0:00 42:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Retina Channel Podcast?

This episode is 42 minutes long.

When was this The Retina Channel Podcast episode published?

This episode was published on March 13, 2021.

Can I download this The Retina Channel Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!